Verona Pharma debuts IPO

London-based Verona Pharma, a biopharmaceutical company, has priced its IPO of over 5.8 million shares at $13.50 per share. The stock began trading April 27, 2017 on the NASDAQ under the ticker symbol “VRNA.” Jefferies and Stifel are serving as the lead underwriters. Verona Pharma’s backers include Vivo Capital, OrbiMed, New Enterprise Associates, Abingworth, Henderson Global Investors and Aisling Capital.

DealsNorth AmericaUSBriefs